POSTMENOPAUSAL OSTEOPOROSIS
Clinical trials for POSTMENOPAUSAL OSTEOPOROSIS explained in plain language.
Never miss a new study
Get alerted when new POSTMENOPAUSAL OSTEOPOROSIS trials appear
Sign up with your email to follow new studies for POSTMENOPAUSAL OSTEOPOROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Bone-Boosting drug shows promise for women with osteoporosis
Disease control OngoingThis study tests a new medicine called AGA2118 in postmenopausal women aged 55 to 80 who have low bone density but no prior fractures. The goal is to see if it can safely increase bone strength in the spine and hips compared to a placebo over 12 months. Participants will receive …
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Phase: PHASE2 • Sponsor: Angitia Biopharmaceuticals • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
Bone-Building drug showdown: which works better for osteoporosis?
Disease control OngoingThis study looks at how well two approved medications help strengthen bones in postmenopausal women who are at high risk for fractures. About 50 women will take one of the drugs for 12 months, and researchers will measure changes in hip bone density. The goal is to find which tre…
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 05:45 UTC